Covered recipient · General Payments record
AMBER KYLE
General Payments · PY2019–2024
$564.03
- Reported across 25 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $257.15 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $69.96 | 3 |
| GENZYME CORPORATION | $60.66 | 2 |
| Janssen Biotech, Inc. | $42.60 | 2 |
| Amgen Inc. | $38.00 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $31.13 | 1 |
| UCB, Inc. | $14.80 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $23.33 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117303441 | CMS |
| Amgen Inc. | $14.67 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117303443 | CMS |
| E.R. Squibb & Sons, L.L.C. | $26.41 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101425782 | CMS |
| E.R. Squibb & Sons, L.L.C. | $18.39 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101425810 | CMS |
| E.R. Squibb & Sons, L.L.C. | $25.16 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101425840 | CMS |
| GENZYME CORPORATION | $39.08 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139834948 | CMS |
| GENZYME CORPORATION | $21.58 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139835036 | CMS |
| Janssen Biotech, Inc. | $14.53 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078346712 | CMS |
| Janssen Biotech, Inc. | $28.07 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078346843 | CMS |
| Novartis Pharmaceuticals Corporation | $31.13 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087067088 | CMS |
| UCB, Inc. | $14.80 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143287413 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.